Breast Cancer
Studies from R. Torrisi and co-researchers update current data on breast cancer
Published in Clinical Oncology Week, February 11th, 2008
"The prevalence of HER2 amplification according to the percentage of positively stained cells, of polysomy 17 and their correlation with clinical and pathologic characteristics were retrospectively evaluated in a population of 415 breast cancers where fluorescence in situ hybridisation (FISH) was performed to clarify HER2 status previously determined by immunohistochemistry. Forty-two tumours with intense and complete staining in > 50% of cells were selected from the same database as internal controls," scientists writing in the European Journal of Cancer report.
"Among the 415 cases, 233 tumours were IHC 1+, 168 tumours were 2+ and 14 tumours showed an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Brain Cancer
Drug helps brain tumor patients live longer - Breast Cancer
Breast cancer diagnosis comes late for women in gentrifying neighborhoods - Breast Cancer
Physician characteristics are associated with quality of cancer care - Breast Cancer Screening
Digital mammography superior to film mammography in some cases - Cancer
A taxing issue: How human T-lymphotropic virus - Cancer
Researchers investigate links between prostate, cadmium, zinc - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
